A pilot study on the diagnostic value of serum parathyroid hormone in diabetic foot osteomyelitis and its correlation with inflammatory markers

Objective To investigate the diagnostic value of serum bone metabolism markers in diabetic foot osteomyelitis (DFO). Methods This pilot, single-center case-control study included 35 patients with DFO and 33 without DFO. All biomarkers were measured from a single fasting blood sample collected after admission. Between-group comparisons were performed using independent-samples t tests or Mann–Whitney U tests. Receiver operating characteristic (ROC) curves were used to evaluate diagnostic performance, and multivariable linear regression assessed associations between parathyroid hormone (PTH) and clinical and biochemical parameters. A sensitivity analysis was performed using biopsy-confirmed DFO cases and non-DFO controls. Results Median serum PTH was higher in the DFO group than in the non-DFO group (34.94 vs. 24.76 ng/L, P = 0.029). The area under the curve (AUC) for PTH was 0.65 (95% confidence interval (CI), 0.52-0.79), compared with 0.74 for white blood cell count (WBC); adding PTH to WBC did not significantly improve discrimination. No significant between-group differences were observed in corrected calcium, serum phosphorus, or the other bone metabolism markers, including alkaline phosphatase (ALP), 25-hydroxyvitamin D [25(OH)D], calcitonin (CT), C-terminal telopeptide of type I collagen (CTX), procollagen type I N-terminal propeptide (P1NP), and osteocalcin (OC) (all P > 0.05). The analysis of 30 biopsy-confirmed DFO cases and 33 non-DFO cases yielded similar findings (PTH AUC = 0.67; 95% CI, 0.53-0.80). In multivariable linear regression, C-reactive protein (CRP) was positively associated with PTH (β = 0.12, 95% CI, 0.03-0.22; P = 0.014), whereas DFO status was not significantly associated with PTH (β = 5.34, 95% CI, -3.29-13.96; P = 0.221). Conclusion Serum PTH concentrations were elevated in patients with DFO and were positively associated with CRP after adjustment. PTH showed a modest AUC of 0.65. Higher PTH levels in patients with DFO may reflect more severe infection rather than osteomyelitis due to inconsistent severity of infection. This pilot study does not support the use of bone metabolism markers as stand-alone diagnostic tests for DFO.

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2026-11-18
DOI
https://doi.org/10.3389/fendo.2026.1987069
Primary Topic
Diabetic Foot Ulcer Assessment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A pilot study on the diagnostic value of serum parathyroid hormone in diabetic foot osteomyelitis and its correlation with inflammatory markers

Lei Dong, Lulu Liu, Guangxin Zhou, Yukun Tao et al.
2 links
Frontiers in Endocrinology
Diabetic Foot Ulcer Assessment and Management
article

A pilot study on the diagnostic value of serum parathyroid hormone in diabetic foot osteomyelitis and its correlation with inflammatory markers

Lei Dong, Lulu Liu, Guangxin Zhou, Yukun Tao, Jinzheng Hou, Da Zhang, Fang Liu, Huijuan Zhu, Li Xiao
article en

Abstract

Objective To investigate the diagnostic value of serum bone metabolism markers in diabetic foot osteomyelitis (DFO). Methods This pilot, single-center case-control study included 35 patients with DFO and 33 without DFO. All biomarkers were measured from a single fasting blood sample collected after admission. Between-group comparisons were performed using independent-samples t tests or Mann–Whitney U tests. Receiver operating characteristic (ROC) curves were used to evaluate diagnostic performance, and multivariable linear regression assessed associations between parathyroid hormone (PTH) and clinical and biochemical parameters. A sensitivity analysis was performed using biopsy-confirmed DFO cases and non-DFO controls. Results Median serum PTH was higher in the DFO group than in the non-DFO group (34.94 vs. 24.76 ng/L, P = 0.029). The area under the curve (AUC) for PTH was 0.65 (95% confidence interval (CI), 0.52-0.79), compared with 0.74 for white blood cell count (WBC); adding PTH to WBC did not significantly improve discrimination. No significant between-group differences were observed in corrected calcium, serum phosphorus, or the other bone metabolism markers, including alkaline phosphatase (ALP), 25-hydroxyvitamin D [25(OH)D], calcitonin (CT), C-terminal telopeptide of type I collagen (CTX), procollagen type I N-terminal propeptide (P1NP), and osteocalcin (OC) (all P > 0.05). The analysis of 30 biopsy-confirmed DFO cases and 33 non-DFO cases yielded similar findings (PTH AUC = 0.67; 95% CI, 0.53-0.80). In multivariable linear regression, C-reactive protein (CRP) was positively associated with PTH (β = 0.12, 95% CI, 0.03-0.22; P = 0.014), whereas DFO status was not significantly associated with PTH (β = 5.34, 95% CI, -3.29-13.96; P = 0.221). Conclusion Serum PTH concentrations were elevated in patients with DFO and were positively associated with CRP after adjustment. PTH showed a modest AUC of 0.65. Higher PTH levels in patients with DFO may reflect more severe infection rather than osteomyelitis due to inconsistent severity of infection. This pilot study does not support the use of bone metabolism markers as stand-alone diagnostic tests for DFO.

Frontiers in EndocrinologyVol. 17
Air Force General Hospital PLA (CN)
Good health and well-being
Diabetic Foot Ulcer Assessment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon